Is Bristol Myers Squibb Stock a Buy?

·5-min read

Bristol Myers Squibb (NYSE: BMY) stock hasn't performed very well so far this year. In this Motley Fool Live video recorded on Sept. 15, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about whether or not the big pharma stock is a buy.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting